Marshall Wace
KYNB

Marshall Wace’s Kyntra Bio KYNB Stock Holding History

Marshall Wace’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,502
Closed -$285K – 3361
2025
Q4 		$285K Sell
32,502
-39,947
-55% -$390K ﹤0.01% 2468
2025
Q3 		$888K Buy
72,449
+149
+0.2% +$1.4K ﹤0.01% 1990
2025
Q2 		$383K Sell
72,300
-16,202
-18% -$118K ﹤0.01% 2237
2025
Q1 		$686K Buy
88,502
+37,881
+75% +$454K ﹤0.01% 1937
2024
Q4 		$671K Sell
50,621
-7,173
-12% -$66.7K ﹤0.01% 1919
2024
Q3 		$578K Buy
+57,794
New +$872K ﹤0.01% 1873
2023
Q1 		– Sell
-30,142
Closed -$12.1M – 2808
2022
Q4 		$12.1M Sell
30,142
-257
-0.8% -$98.4K 0.03% 711
2022
Q3 		$9.89M Buy
+30,399
New +$9.79M 0.02% 898
2021
Q3 		– Sell
-18,434
Closed -$12.3M – 3143
2021
Q2 		$12.3M Buy
+18,434
New +$10.6M 0.06% 388
2019
Q4 		– Sell
-3,133
Closed -$2.9M – 1811
2019
Q3 		$2.9M Buy
+3,133
New +$3.44M 0.02% 654
2019
Q1 		– Sell
-4,958
Closed -$5.74M – 1825
2018
Q4 		$5.74M Buy
+4,958
New +$5.57M 0.06% 407

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Marshall Wace's KYNB Position: Q1 2026 in Review

Marshall Wace sold out of Kyntra Bio (KYNB) in Q1 2026, closing a stake of 32,502 shares — an estimated $285K sold.

Marshall Wace first reported a position in KYNB in Q4 2018 and held it in 11 quarters. The position peaked at $12.3M in Q2 2021. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.

  • Marshall Wace reported no remaining Kyntra Bio position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 32,502 Kyntra Bio shares in Q1 2026, an estimated $285K.
  • Marshall Wace first reported a position in Kyntra Bio in Q4 2018 and held it in 11 quarters.
  • Marshall Wace's Kyntra Bio position peaked at $12.3M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.